SPOTLIGHT: $1B program catalogs cancer triggers

An international consortium of researchers has launched a billion-dollar effort to map every way that changes in DNA contributes to the development of tumors. The newly launched International Cancer Genome Consortium says that they hope to complete their work in less than 10 years as they ambitiously map out a project that is being described as the cancer equivalent of the Human Genome Project. Report

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.